These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 1909632
21. [The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods]. Olbricht CJ. Dtsch Med Wochenschr; 1991 Apr 19; 116(16):625-30. PubMed ID: 2015780 [No Abstract] [Full Text] [Related]
22. Complement profile and activation mechanisms by different LDL apheresis systems. Hovland A, Hardersen R, Nielsen EW, Enebakk T, Christiansen D, Ludviksen JK, Mollnes TE, Lappegård KT. Acta Biomater; 2012 Jul 19; 8(6):2288-96. PubMed ID: 22373816 [Abstract] [Full Text] [Related]
23. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET]. Mellwig KP, Baller D, Schmidt HK, V Buuren F, Wielepp JP, Burchert W, Horstkotte D. Z Kardiol; 2003 Jul 19; 92(Suppl 3):III30-7. PubMed ID: 14663599 [Abstract] [Full Text] [Related]
25. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss. Suckfüll M. Ther Apher; 2001 Oct 19; 5(5):377-83. PubMed ID: 11778923 [Abstract] [Full Text] [Related]
31. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems. Jovin IS, Taborski U, Stehr A, Müller-Berghaus G. Metabolism; 2000 Nov 19; 49(11):1431-3. PubMed ID: 11092506 [Abstract] [Full Text] [Related]
32. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia. Drouin-Chartier JP, Tremblay AJ, Bergeron J, Pelletier M, Laflamme N, Lamarche B, Couture P. J Clin Apher; 2016 Aug 19; 31(4):359-67. PubMed ID: 26011648 [Abstract] [Full Text] [Related]
36. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4. Moriarty PM, Luyendyk JP, Gibson CA, Backes JM. Am J Cardiol; 2010 Jun 01; 105(11):1585-7. PubMed ID: 20494666 [Abstract] [Full Text] [Related]
37. In vitro and in vivo studies with different precipitate filter cartridges for H.E.L.P.-LDL-apheresis. Optimization of precipitate filter cartridges. Morsch G, Maywald F, Wanner C. Bioseparation; 1995 Feb 01; 5(1):11-8. PubMed ID: 7766149 [Abstract] [Full Text] [Related]
38. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia. Zwiener RJ, Uauy R, Petruska ML, Huet BA. J Pediatr; 1995 May 01; 126(5 Pt 1):728-35. PubMed ID: 7751996 [Abstract] [Full Text] [Related]
39. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption. Drouin-Chartier JP, Tremblay AJ, Bergeron J, Lamarche B, Couture P. Atherosclerosis; 2018 Mar 01; 270():26-32. PubMed ID: 29407885 [Abstract] [Full Text] [Related]
40. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating. Stefanutti C, Morozzi C, Perrone G, Di Giacomo S, Vivenzio A, D'Alessandri G. G Chir; 2012 Mar 01; 33(11-12):444-9. PubMed ID: 23140934 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]